Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 791-801

  Rabinowitz, J E ^a   Rolling, F ^a   Li, C ^a   Conrath, H ^a   Xiao, W ^a   Xiao, X ^a   Samulski, R J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; PROTEOHEPARAN SULFATE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHO CELL; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DNA PACKAGING; GENE REPLICATION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; SEROTYPE; TRANSGENE; VIRION;

AMINO ACID SEQUENCE; ANIMALS; CAPSID; CELL LINE; CHROMATOGRAPHY, AFFINITY; CRICETINAE; DEPENDOVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HAPLORHINI; HELPER VIRUSES; HEPARIN; HUMANS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; RATS; RETINA; RODENTIA; SENSITIVITY AND SPECIFICITY; SEROTYPING; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC; TRANSGENES; VIRUS ASSEMBLY;

EID: 0036140216     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.791-801.2002     Document Type: Article

References (50)

1. Isolation of highly infectious and pure adeno-associalted virus type 2 vectors with a single-step gravity-flow column
2. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses
3. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
4. 2 antibody
5. Adeno-associated virus defectiveness and the nature of the adenovirus helper function
6. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
7. Sustained expression of human factor VIII in mice using a parvovirus-based vector
8. Cloning and characterization of adeno-associated virus type 5
9. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
10. Inhibition of PrKX, a novel protein kinase and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2
11. Recombinent adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous sytsem
12. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter
13. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
14. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration
15. Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element
16. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
17. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors
18. Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts
19. Evidence for gene transfer and expression of factor IX in hempophilia B patients treated with an AAV vector
20. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer
21. Selective extraction of polyoma DNA from infected mouse cell cultures
22. Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells
23. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity
24. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids
25. Role for highly regulated Rep gene expression in adeno-associated virus vector production
26. Adeno-associated virus vectors can be effciently produced without helper virus
27. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids
28. AAV Vectors: Is clinical success on the horizon?
29. Adeno-associated virus vectors for gene therapy: More pros than cons?
30. Nucleotide sequencing and generation of an infectious clone of adeno-accociated virus 3
31. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
32. Adeno-associated virus expression systems for gene transfer
33. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography
34. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
35. Factors influencing recombinant adeno-associated virus production
36. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
37. The Rep52 gene product of adeno-associated virus is a DNA helicase with 3′-to-5′ polarity
38. Nucleotide sequence and organization of the adeno-associated virus 2 genome
39. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associted virus type 2 virions
40. Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo
41. Control of adeno-associated virus type 2 cap gene expression: Relative influence of helper virus, terminal repeats, and Rep proteins
42. Subcellular compartmentalization of adeno-associated virus type 2 assembly
43. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection
44. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
45. Gene therapy vectors based on adeno-associated virus type 1
46. Production of high titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
47. Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro
48. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer
49. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield